Mimedx Group, Inc. (MDXG): R&D Expense
$15.10M
Year ended 2025-12-31
$15.38M
Trailing 12 months to 2026-06-30
+5.9%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.10M | +22.3% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $12.34M | -2.6% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $12.66M | -0.3% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $12.70M | +27.9% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $9.93M | n/c | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $11.71M | +5.2% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $11.14M | -29.3% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $15.77M | -11.9% | 2021-03-08, From 2018-01-01 |
| 2017-12-31 | $17.90M | +24.8% | 2020-07-06, From 2017-01-01 |
| 2016-12-31 | $14.34M | n/c | 2020-03-17, From 2016-01-01 |
| 2015-12-31 | $8.41M | +19.3% | 2017-03-01, From 2015-01-01 |
| 2014-12-31 | $7.05M | +45.6% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $4.84M | +67.9% | 2017-02-22, From 2013-01-01 |
| 2012-12-31 | $2.88M | -3.1% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $2.98M | n/c | 2014-03-04, From 2011-01-01 |
| 2010-12-31 | $2.75M | n/a | 2012-03-29, From 2010-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $15.10M | +22.3% |
| Accuray Inc (ARAY) | 2026-06-30 | $37.75M | -21.3% |
| Artivion, Inc. (AORT) | 2025-12-31 | $30.99M | +8.9% |
| Glaukos Corp (GKOS) | 2025-12-31 | $150.61M | +10.4% |
| Tactile Systems Technology Inc (TCMD) | 2025-12-31 | $8.48M | -4.0% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $99.21M | +3.2% |
| Angiodynamics Inc (ANGO) | 2026-05-31 | $29.45M | +12.3% |
| Bioventus Inc. (BVS) | 2025-12-31 | $12.11M | -13.2% |
| PROCEPT BioRobotics Corp (PRCT) | 2025-12-31 | $71.28M | +14.4% |
Compare MDXG, ARAY, AORT, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗